BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
Babalola Ishmael Afolabi, Bolanle Olubunmi Ibitoye, Rosemary Temidayo Ikem, Adeleye Dorcas Omisore, Bukunmi Michael Idowu, David Olubukunmi Soyoye. The Relationship Between Glycaemic Control and Non-Alcoholic Fatty Liver Disease in Nigerian Type 2 Diabetic PatientsJournal of the National Medical Association 2018; 110(3): 256 doi: 10.1016/j.jnma.2017.06.001
2
Aki Juhani Käräjämäki, Risto Bloigu, Heikki Kauma, Y. Antero Kesäniemi, Olli-Pekka Koivurova, Juha Perkiömäki, Heikki Huikuri, Olavi Ukkola. Non-alcoholic fatty liver disease with and without metabolic syndrome: Different long-term outcomesMetabolism 2017; 66: 55 doi: 10.1016/j.metabol.2016.06.009
3
Chung‐Hao Li, Yu‐Tsung Chou, Wei‐Chen Shen, Feng‐Hwa Lu, Yi‐Ching Yang, Jin‐Shang Wu, Chih‐Jen Chang. Increased risks of different grades of non‐alcoholic fatty liver disease in prediabetic subjects with impaired fasting glucose and glucose tolerance, including the isolated glycosylated hemoglobin levels of 5.7–6.4% in a Chinese populationJournal of Diabetes Investigation 2020;  doi: 10.1111/jdi.13268
4
Ghada M. Khafagy, Hatem A. Darwish, Ayman Yosry, Naglaa A. Zayed, Ahmed M. Khairy, Eman I. Elmeshmeshy, Heba G. Elnahas. Non Alcoholic Fatty Liver Disease and Degree of Steatosis in Diabetic and Non- Diabetic patientsObesity Medicine 2020; 19: 100243 doi: 10.1016/j.obmed.2020.100243
5
Xiao Zhai, Xiao Chen, Jiancan Lu, Yaping Zhang, Xuejun Sun, Qin Huang, Qijin Wang. Hydrogen-rich saline improves non-alcoholic fatty liver disease by alleviating oxidative stress and activating hepatic PPARα and PPARγMolecular Medicine Reports 2017; 15(3): 1305 doi: 10.3892/mmr.2017.6120
6
Juergen Sandow. Drug Discovery and Evaluation: Methods in Clinical Pharmacology2020; : 1 doi: 10.1007/978-3-319-56637-5_33-1
7
Mohammad Ghasem Han, Masoud Cina, Mehrnoush Zakerkish, Fakher Rahim, Amal Saki-Maleh, Qasem Nissi. Correlation between Non-Alcoholic Fatty Liver Disease and Carotid Intima-Media Thickness in Patient with Type II DiabetesInternational Journal of Osteoporosis and Metabolic Disorders 2015; 8(2): 35 doi: 10.3923/ijom.2015.35.41
8
Emily J. Gallagher, Derek LeRoith, Marilyn Stasinopoulos, Zara Zelenko, Joseph Shiloach. Polyol accumulation in muscle and liver in a mouse model of type 2 diabetesJournal of Diabetes and its Complications 2016; 30(6): 999 doi: 10.1016/j.jdiacomp.2016.04.019
9
Katsutoshi Maeta, Yu Nishiyama, Kazutoshi Fujibayashi, Toshiaki Gunji, Noriko Sasabe, Kimiko Iijima, Toshio Naito. Prediction of Glucose Metabolism Disorder Risk Using a Machine Learning Algorithm: Pilot StudyJMIR Diabetes 2018; 3(4): e10212 doi: 10.2196/10212
10
Benedetta M. Motta, Christoph Grander, Martin Gögele, Luisa Foco, Vladimir Vukovic, Roberto Melotti, Christian Fuchsberger, Alessandro De Grandi, Chiara Cantaloni, Anne Picard, Deborah Mascalzoni, Alessandra Rossini, Cristian Pattaro, Herbert Tilg, Peter P. Pramstaller. Microbiota, type 2 diabetes and non-alcoholic fatty liver disease: protocol of an observational studyJournal of Translational Medicine 2019; 17(1) doi: 10.1186/s12967-019-02130-z
11
Miriam Rodriguez-Sosa, Tecilli Cabellos-Avelar, Yuriko Sanchez-Zamora, Imelda Juárez-Avelar, Esperanza García-Reyes, Alejandra Lira-León, José del Carmen Benítez-Flores, Thalia Pacheco-Fernández, Marcia Hiriart, Emma Berta Gutiérrez-Cirlos. Proinflammatory cytokine MIF plays a role in the pathogenesis of type-2 diabetes mellitus, but does not affect hepatic mitochondrial functionCytokine 2017; 99: 214 doi: 10.1016/j.cyto.2017.07.012
12
Claudia P. Oliveira, Priscila de Lima Sanches, Erlon Oliveira de Abreu-Silva, Aline Marcadenti. Nutrition and Physical Activity in Nonalcoholic Fatty Liver DiseaseJournal of Diabetes Research 2016; 2016: 1 doi: 10.1155/2016/4597246
13
Tian Shen, Bilin Xu, Tao Lei, Lin Chen, Cuiping Zhang, Zhenhua Ni. Sitagliptin reduces insulin resistance and improves rat liver steatosis via the SIRT1/AMPKα pathwayExperimental and Therapeutic Medicine 2018;  doi: 10.3892/etm.2018.6554
14
Younmi Kim, Heaji Lee, Sun Yeou Kim, Yunsook Lim. Effects of Lespedeza Bicolor Extract on Regulation of AMPK Associated Hepatic Lipid Metabolism in Type 2 Diabetic MiceAntioxidants 2019; 8(12): 599 doi: 10.3390/antiox8120599
15
Oana Irina Gavril, Lidia Iuliana Arhire, Ovidiu Mitu, Radu Sebastian Gavril, Alexandra Mastaleru, Madalina Ioana Zota, Maria-Magdalena Leon-Constantin, Teodor Vasilcu, Laura Mihalache, Florin Mitu. Metabolic Syndrome and Nonalcoholic Fatty Liver DiseaseInternal Medicine 2019; 16(1): 51 doi: 10.2478/inmed-2019-0052
16
Eleni Asprouli, Ioanna Panagiota Kalafati, Aikaterini Sakellari, Sotirios Karavoltsos, John Vlachogiannakos, Konstantinos Revenas, Alexander Kokkinos, Manos Dassenakis, George V. Dedoussis, Nick Kalogeropoulos. Evaluation of Plasma Trace Elements in Different Stages of Nonalcoholic Fatty Liver DiseaseBiological Trace Element Research 2019; 188(2): 326 doi: 10.1007/s12011-018-1432-9
17
Nobuya Inagaki, Wayne H.-H. Sheu, David R. Owens, Susanne Crowe, Amit Bhandari, Yan Gong, Sanjay Patel. Efficacy and safety of linagliptin in type 2 diabetes patients with self-reported hepatic disorders: A retrospective pooled analysis of 17 randomized, double-blind, placebo-controlled clinical trialsJournal of Diabetes and its Complications 2016; 30(8): 1622 doi: 10.1016/j.jdiacomp.2016.07.002
18
Viera Kupčová, Michaela Fedelešová, Jozef Bulas, Petra Kozmonová, Ladislav Turecký. Overview of the Pathogenesis, Genetic, and Non-Invasive Clinical, Biochemical, and Scoring Methods in the Assessment of NAFLDInternational Journal of Environmental Research and Public Health 2019; 16(19): 3570 doi: 10.3390/ijerph16193570
19
Petar Avramovski, Maja Avramovska, Zorica Nikleski, Biljana Ilkovska, Kosta Sotiroski, Emilija Sikole. The predictive value of the hepatorenal index for detection of impaired glucose metabolism in patients with non-alcoholic fatty liver diseaseIndian Journal of Gastroenterology 2020; 39(1): 50 doi: 10.1007/s12664-019-01009-7
20
Rosa María Piña-Zentella, Jorge L. Rosado, Marco A. Gallegos-Corona, Luis Alberto Madrigal-Pérez, Olga P. García, Minerva Ramos-Gomez. Lycopene Improves Diet-Mediated Recuperation in Rat Model of Nonalcoholic Fatty Liver DiseaseJournal of Medicinal Food 2016; 19(6): 607 doi: 10.1089/jmf.2015.0123
21
Nobuyuki Toshikuni, Mutsumi Tsuchishima, Atsushi Fukumura, Tomiyasu Arisawa, Mikihiro Tsutsumi. Associations of Fatty Liver Disease with Hypertension, Diabetes, and Dyslipidemia: Comparison between Alcoholic and Nonalcoholic SteatohepatitisGastroenterology Research and Practice 2017; 2017: 1 doi: 10.1155/2017/9127847
22
Juergen Sandow. Drug Discovery and Evaluation: Methods in Clinical Pharmacology2020; : 243 doi: 10.1007/978-3-319-68864-0_33
23
Liang Wang. Ultrasound-Diagnosed Nonalcoholic Fatty Liver Disease Independently Predicts a Higher Risk of Developing Diabetes Mellitus in Nonoverweight IndividualsAcademic Radiology 2019; 26(7): 863 doi: 10.1016/j.acra.2018.08.019
24
Philip N. Newsome, Melissa Palmer, Bradley Freilich, Muhammad Y. Sheikh, Aasim Sheikh, Harry Sarles, Robert Herring, Parvez Mantry, Zeid Kayali, Tarek Hassanein, Hak-Myung Lee, Guruprasad P. Aithal. Volixibat in adults with non-alcoholic steatohepatitis: 24-week interim analysis from a randomized, phase II studyJournal of Hepatology 2020; 73(2): 231 doi: 10.1016/j.jhep.2020.03.024
25
Jiaorong Tan, Jiahong Xu, Guohua Wei, Lijuan Zhang, Long’e Sun, Guangyu Wang, Fei Li, Fengxiang Jiang. HNF1α Controls Liver Lipid Metabolism and Insulin Resistance via Negatively Regulating the SOCS-3-STAT3 Signaling PathwayJournal of Diabetes Research 2019; 2019: 1 doi: 10.1155/2019/5483946
26
Edison Roberto PARISE. NONALCOHOLIC FATTY LIVER DISEASE (NAFLD), MORE THAN A LIVER DISEASEArquivos de Gastroenterologia 2019; 56(3): 243 doi: 10.1590/s0004-2803.201900000-45
27
Amedeo Lonardo, Stefano Ballestri, Giovanni Guaraldi, Fabio Nascimbeni, Dante Romagnoli, Stefano Zona, Giovanni Targher. Fatty liver is associated with an increased risk of diabetes and cardiovascular disease - Evidence from three different disease models: NAFLD, HCV and HIVWorld Journal of Gastroenterology 2016; 22(44): 9674-9693 doi: 10.3748/wjg.v22.i44.9674
28
Mehmet Sayiner, Aaron Koenig, Linda Henry, Zobair M. Younossi. Epidemiology of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis in the United States and the Rest of the WorldClinics in Liver Disease 2016; 20(2): 205 doi: 10.1016/j.cld.2015.10.001
29
Michaela Routhu, Vaclav Safka, Sunil Kumar Routhu, Tomas Fejfar, Vaclav Jirkovsky, Antonin Krajina, Eva Cermakova, Petr Hulek, Ladislav Hosak. Observational Cohort Study of Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt (TIPS)Annals of Hepatology 2017; 16(1): 140 doi: 10.5604/16652681.1226932
30
Signe Foghsgaard, Camilla Andreasen, Louise Vedtofte, Emilie S. Andersen, Emilie Bahne, Charlotte Strandberg, Thora Buhl, Jens J. Holst, Jens A. Svare, Tine D. Clausen, Elisabeth R. Mathiesen, Peter Damm, Lise L. Gluud, Filip K. Knop, Tina Vilsbøll. Nonalcoholic Fatty Liver Disease Is Prevalent in Women With Prior Gestational Diabetes Mellitus and Independently Associated With Insulin Resistance and Waist CircumferenceDiabetes Care 2017; 40(1): 109 doi: 10.2337/dc16-1017
31
Undurti N. Das. Beneficial role of bioactive lipids in the pathobiology, prevention, and management of HBV, HCV and alcoholic hepatitis, NAFLD, and liver cirrhosis: A reviewJournal of Advanced Research 2019; 17: 17 doi: 10.1016/j.jare.2018.12.006
32
Isabel M.A. Brüggenwirth, Natasha H. Dolgin, Robert J. Porte, Adel Bozorgzadeh, Paulo N.A. Martins. Donor Diabetes and Prolonged Cold Ischemia Time Synergistically Increase the Risk of Graft Failure After Liver TransplantationTransplantation Direct 2017; 3(7): e173 doi: 10.1097/TXD.0000000000000692
33
Yvonne Alt, Jörn M. Schattenberg. Derzeit bleiben als Gegenmittel nur Aufmerksamkeit und LebensstilmodifikationInfo Diabetologie 2015; 9(1): 28 doi: 10.1007/s15034-014-0624-4
34
Yuko Tanimura, Wataru Aoi, Katsura Mizushima, Yasuki Higashimura, Yuji Naito. Combined treatment of dipeptidyl peptidase‐4 inhibitor and exercise training improves lipid profile in KK/Ta miceExperimental Physiology 2019; 104(7): 1051 doi: 10.1113/EP087449
35
Eider Talavera-Urquijo, Sarai Rodríguez-Navarro, Marc Beisani, Maria Teresa Salcedo-Allende, Aisha Chakkur, Marc Arús-Avilés, Manel Cremades, Salvador Augustin, María Martell, José M. Balibrea. Morphofunctional Changes After Sleeve Gastrectomy and Very Low Calorie Diet in an Animal Model of Non-Alcoholic Fatty Liver DiseaseObesity Surgery 2018; 28(1): 142 doi: 10.1007/s11695-017-2805-4
36
Ji-Youn Kim, Gyu-Na Lee, Hyun Chul Song, Yong-Moon Park, Yu-Bae Ahn, Kyungdo Han, Seung-Hyun Ko. Association between Fatty Liver Index and Periodontitis: the Korea National Health and Nutrition Examination SurveyScientific Reports 2020; 10(1) doi: 10.1038/s41598-020-60797-7